Prostate Cancer
A Randomized, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localized High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02) (D9727C00001)
- Details
ClinicalTrials.gov ID:
NCT06952803
Diagnosis Type:
NA
USOR Number:
- Address
,
P: